AI Verdict
EPRT has stronger fundamentals based on our AI analysis.
EPRX vs EPRT Fundamental Comparison
| Metric | EPRX | EPRT |
|---|---|---|
| Revenue | N/A | $561.2M |
| Net Income | N/A | $253.0M |
| Net Margin | N/A | 45.1% |
| ROE | N/A | 6.0% |
| ROA | N/A | 3.7% |
| Current Ratio | N/A | N/A |
| Debt/Equity | N/A | 0.60x |
| EPS | N/A | $1.28 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
EPRX vs EPRT: Frequently Asked Questions
Is EPRX or EPRT a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), EPRT has stronger fundamentals. EPRX is rated SELL (95% confidence) while EPRT is rated BUY (78% confidence). This is not investment advice.
How does EPRX compare to EPRT fundamentally?
EUPRAXIA PHARMACEUTICALS INC. has ROE of N/A vs ESSENTIAL PROPERTIES REALTY TRUST, INC.'s 6.0%. Net margins are N/A vs 45.1% respectively.
Which stock pays higher dividends, EPRX or EPRT?
EPRX has a dividend yield of N/A or no dividend while EPRT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in EPRX or EPRT for long term?
For long-term investing, consider that EPRX has SELL rating with 95% confidence, while EPRT has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about EPRX vs EPRT?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EPRX vs EPRT, the AI consensus favors EPRT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.